Search

Courtney Davies (Massey University, New Zealand) and colleagues published a new paper in Frontiers in Microbiology showing that Mycobacteriophage endolysins can kill Mycobacteria when fused to 'PLAN-M' biodegradable nanobeads, which can be

Martin Loessner and Rob Lavigne co-edited a special issue of Current Opinion in Biotechnology dedicated to phage, entitled Nanobiotechnology — Phage Therapy. The issue is now complete: check out the 21 articles here!

Aquaculture feed company Skretting and phage biotech company Proteon Pharmaceuticals are joining forces to trial phages to improve fish and shrimp health. Skretting will isolate strains of bacteria they'd like to target, and Proteon will de

Hanson Wade The 2nd Hanson Wade Bacteriophage Therapy Summit takes place (virtually) Aug 27-28, and registration is open! We (Jessica and Jan, Phage Directory) are excited to be participating in a panel discussion/workshop alongside Dr. Au

Invitris is a new team out of TU Munich funded to spin off a phage therapy biotech company based on their unique synthetic phage production system. They're looking for an additional team member at the intersection of microbiology and the cl

My client, a Northeast US-based CRO, wants to hire a Microbiologist with phage experience for their phage and other contract research programs to provide lab-bench and technical support, especially taking a lead with phage-based programs.

Armata Pharmaceuticals, a phage therapy biotech company in Los Angeles, is hiring for several positions.

Bartłomiej Grygorcewicz (Pomeranian Medical University in Szczecin, Poland) and colleagues published a new paper in Microbial Drug Resistance showing that Acinetobacter baumannii phages could reduce biofilm biomass in a human urine model, a

FixedPhage (Glasgow, Scotland) is hiring a Technical Manager, who will be responsible for building and maintaining the company's production facilities.

Matthew Brown (Laboratory Corporation of America Holdings, North Carolina) and colleagues published a new paper in Viruses on the development and evaluation of a new phage-based MRSA diagnostic screen. The screen uses two luciferase reporte

Eric Sumrall (ETH Zurich) and colleagues published a new paper in Applied and Environmental Microbiology describing a novel phage protein tool kit that can be used for glycotyping and specific separation of Listeria monocytogenes

Ever wondered about phage abundance, diversity or geographic patterns of phage-host interactions in an urban setting like New York City? Kristen Gulino (New York University) and collaborators published a new paper in mSystems showing the in

Bacterial pathogens of fish cause major problems for fish farmers. Bernardo Veyrand‐Quirós (Instituto Politécnico Nacional, Mexico) and colleagues published a new paper in the Journal of Applied Microbiology showing that phage therapy incre

Another story about phage application in marine aquaculture! Hyoun Joong Kim (Seoul National University) and colleagues published a new paper in Microorganisms showing the preventive effects of phage against pathogenic Vibrio coralliilyticu

Dr. Panos Kalatzis gives a detailed interview on starting his biotech company Aquatic Biologicals in Greece, which is using phages to target fish pathogens threatening aquaculture.

EIT Health Catapult in Germany is having a pitch competition for its regional BioTech category finalists, and one of them is PhagoMed, a phage therapy company out of Austria. Tune in May 26 to watch the pitch!

EIT Health Catapult in Germany is having a pitch competition for its regional BioTech category finalists, and one of them is PhagoMed, a phage therapy company out of Austria. Tune in May 26 to watch the pitch!

Dr. Panos Kalatzis gives a detailed interview on starting his biotech company Aquatic Biologicals in Greece, which is using phages to target fish pathogens threatening aquaculture.

James Doub (University of Maryland School of Medicine) and colleagues published their successful eradication of a 72-year-old man's prosthetic joint infection with phage therapy, which was done alongside Adaptive Phage Therapeutics and the

James Doub (University of Maryland School of Medicine) and colleagues published their successful eradication of a 72-year-old man's prosthetic joint infection with phage therapy, which was done alongside Adaptive Phage Therapeutics and the